Solu-delta-cortef (R) Sterile Powder

Hazard statements (CLP)

H361d

Code

Statements

H361d

Suspected of damaging the unborn child

SECTION 2: Hazards identification

Appearance Powder Classification of the Substance or Mixture GHS - Classification Reproductive Toxicity: Category 2 EU Classification EU Indication of danger Harmful EU Symbol Xn EU Risk Phrases RG63 - Possible risk of harm to the unborn child.

Signal word

Warning

Hazard statements

H361d - Suspected of damaging the unborn child

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concemed: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

2.3 Other hazards

Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on the developing fetus. Known Clinical Effects Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. Australian Hazard Classification (NOHSC)

Hazardous Ingredients

Non-Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. ‘Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

- Classification Reproductive Toxicity: Category 2 EU Classification: EU Indication of danger: Harmful EU Symbol: Xn EU Risk Phrases: RG63 - Possible risk of harm to the unborn child. Label Elements